152 related articles for article (PubMed ID: 15199810)
1. [Magnetic resonance imaging in diagnosis of localized prostatic cancer].
Shatov AV; Ognerubov NA
Urologiia; 2004; (3):25-9. PubMed ID: 15199810
[TBL] [Abstract][Full Text] [Related]
2. The value of dynamic MR imaging for hypointensity lesions of the peripheral zone of the prostate.
Namimoto T; Morishita S; Saitoh R; Kudoh J; Yamashita Y; Takahashi M
Comput Med Imaging Graph; 1998; 22(3):239-45. PubMed ID: 9740041
[TBL] [Abstract][Full Text] [Related]
3. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
4. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
[TBL] [Abstract][Full Text] [Related]
5. [The value of diagnostic imaging in benign prostatic hyperplasia and prostatic cancer].
Dörsam J; Kälble T; Riedasch G; Staehler G
Radiologe; 1994 Mar; 34(3):101-8. PubMed ID: 7513894
[TBL] [Abstract][Full Text] [Related]
6. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
[TBL] [Abstract][Full Text] [Related]
7. [Ultrasonography and prostatic adenocarcinoma].
Grasso-Leanza F; Pepe P; Panella P; Pennisi M
Arch Ital Urol Androl; 1995 Sep; 67(4):237-41. PubMed ID: 7581523
[TBL] [Abstract][Full Text] [Related]
8. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study.
Amsellem-Ouazana D; Younes P; Conquy S; Peyromaure M; Flam T; Debré B; Zerbib M
Eur Urol; 2005 May; 47(5):582-6. PubMed ID: 15826747
[TBL] [Abstract][Full Text] [Related]
9. [Magnetic resonance spectroscopy of the prostate: a description of the methodology and the own results].
Kitaev SV; Morozov SP; Zhivov AV
Urologiia; 2014; (5):40-7. PubMed ID: 25807758
[TBL] [Abstract][Full Text] [Related]
10. [Significance and limitations of f/tPSA in differential diagnosis of prostate cancer with tPSA levels between 4 and 10 ng/ml].
Chen ZD; Wei SM; Cai SL
Zhonghua Wai Ke Za Zhi; 2004 May; 42(10):593-5. PubMed ID: 15265401
[TBL] [Abstract][Full Text] [Related]
11. [MRI for troubleshooting detection of prostate cancer].
Beyersdorff D; Hamm B
Rofo; 2005 Jun; 177(6):788-95. PubMed ID: 15902626
[TBL] [Abstract][Full Text] [Related]
12. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
Aksoy Y; Oral A; Aksoy H; Demirel A; Akcay F
Ann Clin Lab Sci; 2003; 33(3):320-3. PubMed ID: 12956448
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment.
Scheidler J; Weöres I; Brinkschmidt C; Zeitler H; Panzer S; Scharf M; Heuck A; Siebels M
Rofo; 2012 Feb; 184(2):130-5. PubMed ID: 22274854
[TBL] [Abstract][Full Text] [Related]
14. Optimum PSA reflex-range.
Benecchi L
Arch Ital Urol Androl; 2006 Jun; 78(2):44-8. PubMed ID: 16929601
[TBL] [Abstract][Full Text] [Related]
15. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
17. Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging.
Coakley FV; Chen I; Qayyum A; Westphalen AC; Carroll PR; Hricak H; Chen MH; Kurhanewicz J
BJU Int; 2007 Jan; 99(1):41-5. PubMed ID: 17227490
[TBL] [Abstract][Full Text] [Related]
18. [Color Doppler echography in the diagnosis of nonspecific granulomatous prostatis: personal experience].
Vespasiani G; Bitelli M; Mele GO; Torelli F; Di Stasi SM; Valitutti M; Virgili G
Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):57-60. PubMed ID: 9162375
[TBL] [Abstract][Full Text] [Related]
19. [Circulating prostatic-specific antigen in benign hypertrophy and localized prostate cancer: can PSA be considered a screening examination for localized cancer?].
Perrin P; Francois O; Maquet JH; Bringeon G; Duteil P; Devonec M
Prog Urol; 1991 Jun; 1(3):419-31. PubMed ID: 1726943
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between benign prostatic hyperplasia and prostate cancer in the transitional zone evaluated by 1H magnetic resonance spectroscopic imaging.
Li SY; Chen M; Wang R; Zhou C
Chin Med Sci J; 2007 Dec; 22(4):238-42. PubMed ID: 18246671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
